# A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers

> **NCT01068223** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 24 (actual)

## Conditions studied

- Histamine Induced Itch

## Interventions

- **DRUG:** A:JNJ-39758979/Placebo #1
- **DRUG:** C:Cetirizine/JNJ-39758979 Matching Placebo
- **DRUG:** B: JNJ-39758979 Matching Placebo /Placebo #2

## Key facts

- **NCT ID:** NCT01068223
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** —
- **Final completion:** 2010-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068223, "A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01068223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*